Physician and patient awareness survey on taking oral hypoglycemic agents, especially once-weekly formulations.

Physician and patient awareness survey on taking oral hypoglycemic agents, especially once-weekly formulations. - Physician and patient awareness survey on taking oral hypoglycemic agents, especially once-weekly formulations.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000042598

Enrollment

1000

Registered

2020-11-30

Start date

2020-11-27

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: *Physicians: Physicians who treat an average of 5 or more type 2 diabetic patients a month *Patients: Type 2 diabetic patients aged 20 years or older who regularly visit medical institutions for the treatment of type 2 diabetes and are prescribed oral hypoglycemic drugs.

Exclusion criteria

Exclusion criteria: Patients: Patients who are already taking the once upon a week oral hypoglycemic drug.

Design outcomes

Primary

Measure	Time frame
Impact of Informed Choice on Physician-Patient Consciousness Gap on Weekly Oral Hypoglycemic Drugs.	—

Countries

Japan

Contacts

Public ContactYuriko Kitahara

QLife Co., Ltd. SST

y-kitahara@qlife.co.jp03-6860-5020

Outcome results